Eugenia Litz is appointed as Vice President Investor Relations of Ipsen
Ipsen today announced the appointment of Eugenia Litz as Vice President Investor Relations for the Ipsen Group, effective today. She will report to Aymeric Le Chatelier, Executive Vice President, Chief Financial Officer.
Eugenia Litz takes over Stéphane Durant des Aulnois nominated Finance Director Iberia.
Eugenia will manage the Ipsen Group financial communication and build strong relations with investors and the financial community.
Eugenia holds a BA in Biological Sciences from Northwestern University Illinois and started her career as a clinical research associate, focusing on cardiovascular and gastrointestinal therapeutic areas. In 2001, she became a market research analyst for Frost & Sullivan and then equity research analyst at Avondale Partners and at Thomas Weisel Partners. In 2006, she joined BioMarin Pharmaceutical, a listed US biotech company in California to create the Investor Relations function. Since 2014, she was Director, Investor Relations for AstraZeneca PLC in London (UK).